47 results on '"Reißing, Johanna"'
Search Results
2. Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPS
3. Type-I interferon shapes peritoneal immunity in cirrhosis and drives caspase-5-mediated progranulin release upon infection
4. Th2 Cell Activation in Chronic Liver Disease Is Driven by Local IL33 and Contributes to IL13-Dependent Fibrogenesis
5. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
6. Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease
7. SAT-549 Neutrophil-derived miRNA-223 modulates peritoneal immunity in patients with cirrhosis during spontaneous bacterial peritonitis
8. SAT-534 Macrophage-derived IL-15 imprints peritoneal tissue-resident memory T cells during spontaneous bacterial peritonitis in patients with cirrhosis
9. SAT-545 Th2 cell activation in chronic liver disease is driven by local IL-33 and contributes to IL-13 dependent fibrogenesis
10. Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis
11. Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality
12. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis
13. Functional role of CCL5/RANTES for HCC progression during chronic liver disease
14. Inactivation of caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasis
15. PNPLA3 I148M substitution excerbate NAFLD under a long-term high fat diet
16. Microbiota-targeted interventions in the gut-liver axis for chronic liver disease of DUAL etiology
17. The beneficial effects of the diet withdrawal and physical exercise on steatohepatitis of DUAL etiology
18. Long‐term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals
19. PNPLA3 I148M polymorphism aggravate metabolic liver disease under Long-term high fat diet
20. Membrane-bound and soluble immune checkpoints are abundant in ascitic fluid from patients with decompensated cirrhosis
21. SAT-135 Soluble urokinase plasminogen activator receptor (suPAR) levels predict survival in patients with portal hypertension undergoing TIPS
22. A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
23. Additional file 1 of Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis
24. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
25. Gender-related differences in response to DUAL diet in murine model of steatohepatitis
26. Activation of the unfolded protein response (UPR) and fibrosis is associated withcholangiocellular injury in an experimental model of fibropolycystic liver disease
27. The immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality
28. A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
29. Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
30. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)
31. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)
32. Supplementary materials: A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
33. A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
34. An Experimental DUAL Model of Advanced Liver Damage
35. An Experimental DUAL Model of Advanced Liver Damage
36. WED-470 - PNPLA3 I148M substitution excerbate NAFLD under a long-term high fat diet
37. THU-235 - Microbiota-targeted interventions in the gut-liver axis for chronic liver disease of DUAL etiology
38. FRI-412 - The beneficial effects of the diet withdrawal and physical exercise on steatohepatitis of DUAL etiology
39. Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
40. PS-159-Intestinal dysbiosis fuels liver disease progression via NLRP3 in the Mdr2−/− mouse model of primary sclerosing cholangitis
41. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
42. Functional role of CCL5/RANTES for HCC progression during chronic liver disease
43. Functional role of CCL5/RANTES for HCC progression during chronic liver disease
44. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
45. Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease.
46. Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality.
47. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.